Dr Hoa Thi Xuan Le, RPH | |
2360 W Indian Trl, Aurora, IL 60506-1570 | |
(630) 907-2041 | |
Not Available |
Full Name | Dr Hoa Thi Xuan Le |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 2360 W Indian Trl, Aurora, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205543691 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 051.305180 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Hoa Thi Xuan Le, RPH 7300 W North Ave Apt 4l, Elmwood Park, IL 60707-4247 Ph: (978) 602-5577 | Dr Hoa Thi Xuan Le, RPH 2360 W Indian Trl, Aurora, IL 60506-1570 Ph: (630) 907-2041 |
News Archive
Jim, I'm a doctor, not a device developer! Remember how in Star Trek, Dr. McCoy could point his tricorder at things and magically -; oops, I mean, "scientifically" -; determine all kinds of chemical components and medical diagnoses? The X Prize Foundation -; best known for offering prizes for space flight and cheap genome decoding -; is about to put up $10 million for the invention of a medical device in the spirit of that tricorder: It must be able to diagnose 15 common medical conditions within three days, with no intervention from a health care professional.
Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20.
A pair of studies by researchers at the University of Massachusetts Medical School, the University of Trento in Italy, and the University of Geneva in Switzerland, point to a promising new anti-retroviral strategy for combating HIV-1.
Vitamin D in excess may not be beneficial and may even harm the heart says a new study. Scientists have long known that low levels of the nutrient can hurt the heart, but new research shows that higher than normal levels can make it beat too fast and out of rhythm, a condition called atrial fibrillation. The study was presented at the annual meeting of the American Heart Association.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
› Verified 4 days ago
Dr. Binh T Dinh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1207 N Randall Rd, Aurora, IL 60506 Phone: 630-897-7112 | |
Mr. Minal Samir Patel, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1221 N Lake St, Aurora, IL 60506 Phone: 630-264-6269 | |
Christina Cross, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1157 N Eola Rd, Aurora, IL 60502 Phone: 815-600-4763 | |
Mr. Mohamad Kasar, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2919 Shelly Ln, Aurora, IL 60504 Phone: 630-854-5666 | |
David Bruce Hauge, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2986 Kirk Rd, Aurora, IL 60502 Phone: 847-375-0570 | |
Jimit Baxi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2986 Kirk Road, Aurora, IL 60502 Phone: 630-375-0570 | |
Sonia K Anderson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9 N Union St, Aurora, IL 60505 Phone: 630-585-7594 Fax: 630-585-7620 |